Experts raise alarm over declining effect of last-line antibiotics

Last-line antibiotics against serious pneumonia and bloodstream infections are under real threat in Europe as resistant strains of bacteria emerge, experts are warning.

A new report from the European Centre for Disease Prevention and Control (ECDC) reveals that resistance has continued to increase across Europe in spite of attempts to raise global awareness of the danger to the fundamentally important antibiotic class of drugs. Without them, some infectious diseases could become untreatable and some forms of major surgery would again become perilous.

The report shows that antibiotic resistance continued to increase between 2012 and 2015 across the EU for most of the bacteria and drugs that are being monitored.

Particularly worrying is the increase in resistance to antibiotics considered the last line, where there are no new drugs to treat patients with certain serious infections.

In the Klebsiella bacteria, which is responsible for dangerous pneumonia infections, resistance to the antibiotic class called the carbapenems increased from 6.2% in 2012 to 8.1% in 2015. Combined resistance to carbapenems and polymyxins, such as the antibiotic colistin, was reported in some countries.

Antibiotic use went up in hospitals across the EU, although it went down in community settings in six countries.

Vytenis Andriukaitis, the European commissioner for health and food safety, said: “Antibiotic resistance is one of the most pressing public health issues of our time. If we don’t tackle it, we can go back to a time when even the simplest medical operations were not possible and organ transplants, cancer chemotherapy or intensive care even less so.

“The European commission will launch a new action plan next year so that we can, together with our partners in the EU member states and internationally, continue to ensure that the prevention and control of antibiotic resistance is strengthened within a one-health approach.”

There are concerns about the rise of strains of E coli that are resistant to antibiotics. The bacteria is a frequent cause of infections to the bloodstream and urinary tract, which could become harder to treat.

Widespread publicity about the dangers of the “superbug” MRSA (methicillin-resistant staphylococcus aureus) and efforts to increase hygiene in hospitals brought the levels down between 2012 and 2015, but eight out of 30 countries still have levels of resistance of 25%, making it a public health priority.

Dr Andrea Ammon, the acting director of the ECDC, said there was a lot of variation in the picture around Europe, but generally the proportions of resistant bacteria were higher in the southern and southeastern European countries.

“Multidrug resistance is worrying,” she said. “We also have some reports of combined resistance against so-called last line antibiotics.”

These drugs, which include the carbapenems and colistin, are usually kept in reserve for infections that other drugs can no longer treat.

There have been single reports of resistance to the last-line antibiotic colistin in the Czech Republic, France, Germany, Greece, Italy, Poland and Romania.

“It is not a large problem but it exists. Whenever we have something like this and don’t take good care, it spreads,” she said.

New classes of antibiotic drug are needed, butAmmon said: “We know what can be done and what should be done right now regardless of what new drugs come along. We must try to do the utmost to make the current antibiotics last as long as possible.”

That meant using them prudently and only when necessary and at the right dosage, as well as careful hand hygiene control, especially in hospitals.

Experts raise alarm over declining effect of last-line antibiotics

HIV Charges Declining In U.S., Research Reviews

In accordance to a study letter published in JAMA by researchers from the CDC, rates of HIV diagnosis in the US declined from 2002-2011.  This end result is the conclusion of data examined from the Nationwide HIV Surveillance Program at the CDC.

HIV is the virus accountable for leading to AIDS, which weakens and ravages the immune technique. The WHO estimates that there are about 35 million people throughout the world with HIV, with about one.one million persons in the US living with HIV, even though they could not be unaware of it.

The CDC issued a recommendation for program testing in 2006 for all persons aged 13-64. In accordance to data from the CDC, the percentage of adults examined went up from 37 to 45 percent from 2000 to 2010. Virtually 50,000 folks are diagnosed annually with HIV based mostly on latest CDC data.

Based on benefits of this study–coming from all of the 50 US State overall health departments–the yearly HIV diagnosis charge decreased by 33.2% from 22.1 per a hundred,000 population in 2002 to sixteen.one in 2011.  Statistically significant decreases were mentioned in virtually every demographic, with the biggest percentage modifications noticed in women among the ages of 35-44.

Declines were observed in those with injection drug use, as properly as heterosexual get in touch with. Nonetheless, diagnoses connected with male-to-male sexual make contact with were unchanged, with an improve witnessed in males 13-24, 45-54, and age better than 55.  There was also an observed lessen in HIV rates observed in men getting intercourse with men (MSM) in the ages of 35-44.  The greatest enhance, however, was observed in MSM among the ages of 13-24.

One particular caveat, the researchers of the review acknowledge, is that trends observed in costs of diagnoses can be affected by alterations in approaches to testing populations. As a rule, as testing is increased more than a study time period, diagnoses normally improve, then level off or plateau at some level.

In this examine, even so, there had been decreases noticed in a number of sub-groups, despite the fact that testing was elevated in the examine time period. The researchers explain that even though there was an increase in younger men (13-24) having sex with guys, individuals usually in such substantial chance categories do not undergo yearly exams as usually as other groups, which may possibly have manufactured impacted the capacity to make an accurate comparison.

Whilst the CDC consistently reviews diagnosis costs of about 50,000 new circumstances of HIV yearly, it may be possible that new infections are, in truth, decreasing–but are then supported by an boost in cases of subgroups of guys getting intercourse with males.

In the previous decade, there has been an increased target on the use of antiretroviral therapy for increasing survival and decreasing transmission of the HIV virus, along with the use of pre-publicity prophylaxis (PrEP) which has shown promise in decreasing charges of transmission of HIV in large threat groups by up to 90%.

HIV Charges Declining In U.S., Research Reviews

Death Charges From Pancreatic Cancer Proceed To Climb: Most Other Cancers Declining In Europe

Based on a new examine published in the journal Annals of Oncology on April 23, 
death costs in Europe from pancreatic cancer continue to improve in each guys and women in 2014–lung cancer is noted to be escalating in females as effectively.

The research demonstrated nevertheless that the proportion of deaths attributed to any type of cancer is predicted to decline in Europe in 2014. Even so, pancreatic cancer is the only type of cancer in which growing death rates are predicted for each males and women this year, as effectively as lung cancer in females.

“Our predictions for 2014 confirm that pancreatic death costs are continuing to enhance total,” mentioned Dr. Carlo La Vecchia, lead author of the study.

Towards a peak in costs of cancer observed in 1988, there has been an general decrease of 26% in cancer deaths in males and twenty% in ladies in the EU.

This translates to “over 250,000 cancer deaths averted this year,” explained La Vecchia.

However, as La Vecchia explains, “this year we predict that 41,300 males and 41,000 women will die from pancreatic cancer – an age standardized price of eight. and 5.6 deaths respectively per 100,000 of the population.” “This represents a modest but regular boost because the starting of this century amongst 2000-2004 death charges from the ailment had been 7.6 per 100,000 guys and five. per a hundred,000 women”

“The increased death price is cause for concern, because the prognosis for this tumour is bleak, with less than five percent of pancreatic cancer sufferers surviving for five years soon after diagnosis,” stated La Vecchia.

“As so couple of sufferers survive, the improve in deaths is really closely related to the increase in incidence of this ailment. This tends to make pancreatic cancer a priority for obtaining greater ways to prevent and control it and much better remedies,” additional LaVecchia.

Established danger aspects for pancreatic cancer contain  family background of pancreatic cancer,  smoking, obesity, diabetes and extreme alcohol intake.

“To date, we have no promising therapy for pancreatic cancer. Prevention stays, therefore, the only chance, with smoking cessation 1st, plus control of obese and diabetes. Even so, tobacco accounts for less than a third of all circumstances of pancreatic cancer, and all the other leads to together account for an additional ten %. More work wants to be done to discover other feasible triggers,” said Prof La Vecchia.

Dr. Stephanie Bernik, Chief of Surgical Oncology at Lenox Hill Hospital in New York City agreed with the conclusions of the authors of the study.

“Most of the news from this report is favorable, as the charge of death from most cancers is dropping. It is unfortunate that the fee of death and the incidence of pancreatic cancer continues to rise. This is one particular of the varieties of cancers exactly where we have failed to make progress in both prevention and cure.”

“As we discover more about the brings about of cancer on the cellular degree, the hope is that we will obtain insight as to how to irradiate the condition, additional Bernik.

The Annals study estimates that 742,500 males and 581,one hundred girls will die from cancer in 2014 in the EU. Whilst the actual absolute numbers have elevated when compared with 2009 due to the elevated numbers of elderly men and women, the price (age-adjusted per a hundred,000 of the population) of people who die from the disease has dropped from 148.three male and 89.1 female deaths per 100,000 in 2009 to 138.one deaths and 84.seven per 100,000 estimated for 2014. As a outcome, there has been 7% decline amid guys and five% decline amid women, since 2009.

Investigators centered on pancreatic cancer due to its damaging trends. In men, estimated charges for the 3 key cancers (lung, colorectal and prostate cancer) have fallen by 8%, four% and 10% respectively considering that 2009. In girls, breast and colorectal cancer death rates will fall by 9% and seven% respectively, but lung cancer death costs will rise by eight%.

“Deaths between males are 63% increased than in females, but they are falling faster, due mostly to the history of different smoking patterns in the two sexes. Lung cancer in guys peaked in the late 1980s and has been falling because, whilst charges of lung cancer continue to rise in women,” supplied La Vecchia.

Death Charges From Pancreatic Cancer Proceed To Climb: Most Other Cancers Declining In Europe